Metabolic syndrome is a risk factor for contrast-induced nephropathy after percutaneous coronary intervention

被引：0
|
作者：
Ozcan, O. U. [1 ]
Er, H. Adanir [1 ]
Gulec, S. [1 ]
Kaya, C. Tulunay [1 ]
Akbulut, I. M. [1 ]
Baris, V. O. [1 ]
Atmaca, Y. [1 ]
Erol, C. [1 ]
机构：
[1] Ankara Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6089
引用
收藏
页码：1071 / 1071
页数：1
相关论文
共 50 条
  • [21] Angiotensin Converting Enzyme Therapy and the Risk of Contrast-induced Nephropathy After Coronary Angiography and Percutaneous Coronary Intervention
    Wasilewski, Melissa
    Choxi, Ravi
    Patel, Kalpesh
    Danyi, Peter
    Perera, Robert
    Jovin, Ion S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40
  • [22] Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention?
    Silvain, Johanne
    Collet, Jean-Philippe
    Montalescot, Gilles
    EUROPEAN HEART JOURNAL, 2014, 35 (23) : 1504 - 1506
  • [23] Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
    Shoukat, Sana
    Gowani, Saqib A.
    Jafferani, Asif
    Dhakam, Sajid H.
    CARDIOLOGY RESEARCH AND PRACTICE, 2010, 2010
  • [24] Contrast-Induced Nephropathy in Patients Undergoing Emergency Percutaneous Coronary Intervention for Acute Coronary Syndrome
    Senoo, Takeshi
    Motohiro, Masayuki
    Kamihata, Hiroshi
    Yamamoto, Satoshi
    Isono, Tsuyoshi
    Manabe, Kenichi
    Sakuma, Takao
    Yoshida, Susumu
    Sutani, Yasuo
    Iwasaka, Toshiji
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (05): : 624 - 628
  • [25] Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention
    Araujo, Gustavo N.
    Wainstein, Marco V.
    McCabe, James M.
    Huang, Pei-Hsiu
    Govindarajulu, Usha S.
    Resnic, Frederic S.
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2016, 29 (05) : 447 - 453
  • [26] A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention
    Lin, Kai-yang
    Zheng, Wei-ping
    Bei, Wei-jie
    Chen, Shi-qun
    Islam, Sheikh Mohammed Shariful
    Liu, Yong
    Xue, Lin
    Tan, Ning
    Chen, Ji-yan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 230 : 402 - 412
  • [27] A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes
    Yao, Zhi-Feng
    Shen, Hong
    Tang, Min-Na
    Yan, Yan
    Ge, Jun-Bo
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 (02) : 305 - 314
  • [28] Blood Transfusion and the Risk of Contrast-Induced Nephropathy Among Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
    Karrowni, Wassef
    Vora, Amit N.
    Dai, Dadi
    Wojdyla, Daniel
    Dakik, Habib
    Rao, Sunil
    CIRCULATION, 2015, 132
  • [29] Rotational atherectomy-based percutaneous coronary intervention and the risk of contrast-induced nephropathy
    Demir, Ozan M.
    Poletti, Enrico
    Lombardo, Francesca
    Laricchia, Alessandra
    Beneduce, Alessandro
    Maccagni, Davide
    Cappelletti, Alberto
    Colombo, Antonio
    Bellini, Barbara
    Ancona, Marco B.
    Carlino, Mauro
    Chieffo, Alaide
    Montorfano, Matteo
    Azzalini, Lorenzo
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (02): : 137 - 145
  • [30] THE RISK FACTORS OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
    QiaoPing
    Wangsheng
    Wangwei
    Libin, Chengguanliang
    HEART, 2011, 97
12345